Literature DB >> 18832687

PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue.

Brent H Koehn1, Mandy L Ford, Ivana R Ferrer, Keshawna Borom, Shivaprakash Gangappa, Allan D Kirk, Christian P Larsen.   

Abstract

Peripheral mechanisms of self-tolerance often depend on the quiescent state of the immune system. To what degree such mechanisms can be engaged in the enhancement of allograft survival is unclear. To examine the role of the PD-1 pathway in the maintenance of graft survival following blockade of costimulatory pathways, we used a single-Ag mismatch model of graft rejection where we could track the donor-specific cells as they developed endogenously and emerged from the thymus. We found that graft-specific T cells arising under physiologic developmental conditions at low frequency were actively deleted at the time of transplantation under combined CD28/CD40L blockade. However, this deletion was incomplete, and donor-specific cells that failed to undergo deletion up-regulated expression of PD-1. Furthermore, blockade of PD-1 signaling on these cells via in vivo treatment with anti-PD-1 mAb resulted in rapid expansion of donor-specific T cells and graft loss. These results suggest that the PD-1 pathway was engaged in the continued regulation of the low-frequency graft-specific immune response and thus in maintenance of graft survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832687      PMCID: PMC2572818          DOI: 10.4049/jimmunol.181.8.5313

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.

Authors:  C P Larsen; E T Elwood; D Z Alexander; S C Ritchie; R Hendrix; C Tucker-Burden; H R Cho; A Aruffo; D Hollenbaugh; P S Linsley; K J Winn; T C Pearson
Journal:  Nature       Date:  1996-05-30       Impact factor: 49.962

2.  The time course of CTLAIg effect on cardiac allograft rejection.

Authors:  S F Bolling; H Lin; L A Turka
Journal:  J Surg Res       Date:  1996-06       Impact factor: 2.192

3.  CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.

Authors:  A D Kirk; D M Harlan; N N Armstrong; T A Davis; Y Dong; G S Gray; X Hong; D Thomas; J H Fechner; S J Knechtle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

4.  Analysis of the B7 costimulatory pathway in allograft rejection.

Authors:  T C Pearson; D Z Alexander; M Corbascio; R Hendrix; S C Ritchie; P S Linsley; D Faherty; C P Larsen
Journal:  Transplantation       Date:  1997-05-27       Impact factor: 4.939

5.  Transplantation tolerance induced by CTLA4-Ig.

Authors:  T C Pearson; D Z Alexander; K J Winn; P S Linsley; R P Lowry; C P Larsen
Journal:  Transplantation       Date:  1994-06-27       Impact factor: 4.939

6.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.

Authors:  Y Agata; A Kawasaki; H Nishimura; Y Ishida; T Tsubata; H Yagita; T Honjo
Journal:  Int Immunol       Date:  1996-05       Impact factor: 4.823

7.  Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.

Authors:  A D Kirk; L C Burkly; D S Batty; R E Baumgartner; J D Berning; K Buchanan; J H Fechner; R L Germond; R L Kampen; N B Patterson; S J Swanson; D K Tadaki; C N TenHoor; L White; S J Knechtle; D M Harlan
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

8.  Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.

Authors:  Brian T Fife; Indira Guleria; Melanie Gubbels Bupp; Todd N Eagar; Qizhi Tang; Helene Bour-Jordan; Hideo Yagita; Miyuki Azuma; Mohamed H Sayegh; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-11-20       Impact factor: 14.307

9.  Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance.

Authors:  T Wekerle; M H Sayegh; J Hill; Y Zhao; A Chandraker; K G Swenson; G Zhao; M Sykes
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

10.  CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.

Authors:  M H Sayegh; E Akalin; W W Hancock; M E Russell; C B Carpenter; P S Linsley; L A Turka
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more
  27 in total

1.  CD28 blockade induces division-dependent downregulation of interleukin-2 receptor alpha.

Authors:  Mandy L Ford; Linda L Stempora; Christian P Larsen
Journal:  Transpl Immunol       Date:  2010-11-10       Impact factor: 1.708

2.  Minor antigens on transfused RBCs crossprime CD8 T cells but do not induce full effector function.

Authors:  M Desmarets; G Mylvaganam; E K Waller; C D Josephson; C Pack; A E Lukacher; J C Zimring
Journal:  Am J Transplant       Date:  2011-09       Impact factor: 8.086

3.  Co-inhibitory molecules: Controlling the effectors or controlling the controllers?

Authors:  Govindarajan Thangavelu; Christa Smolarchuk; Colin C Anderson
Journal:  Self Nonself       Date:  2010-02-16

4.  PD-1 expression on CD8+ T cells regulates their differentiation within lung allografts and is critical for tolerance induction.

Authors:  T Takahashi; H M Hsiao; S Tanaka; W Li; R Higashikubo; D Scozzi; A Bharat; J H Ritter; A S Krupnick; A E Gelman; D Kreisel
Journal:  Am J Transplant       Date:  2017-08-23       Impact factor: 8.086

5.  IL-7 receptor blockade following T cell depletion promotes long-term allograft survival.

Authors:  Hoa-Le Mai; Françoise Boeffard; Julie Longis; Richard Danger; Bernard Martinet; Fabienne Haspot; Bernard Vanhove; Sophie Brouard; Jean-Paul Soulillou
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

Review 6.  T-cell exhaustion in allograft rejection and tolerance.

Authors:  Edward B Thorp; Christian Stehlik; M Javeed Ansari
Journal:  Curr Opin Organ Transplant       Date:  2015-02       Impact factor: 2.640

7.  Epigenetic Remodeling in Exhausted T Cells: Implications for Transplantation Tolerance.

Authors:  Sonia J Laurie; Mandy L Ford
Journal:  Transplantation       Date:  2017-05       Impact factor: 4.939

8.  Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.

Authors:  Jeffrey E Teigler; Gennadiy Zelinskyy; Michael A Eller; Diane L Bolton; Mary Marovich; Alexander D Gordon; Aljawharah Alrubayyi; Galit Alter; Merlin L Robb; Jeffrey N Martin; Steven G Deeks; Nelson L Michael; Ulf Dittmer; Hendrik Streeck
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 9.  T Cell Cosignaling Molecules in Transplantation.

Authors:  Mandy L Ford
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 10.  Role of the PD-1 pathway in the immune response.

Authors:  L V Riella; A M Paterson; A H Sharpe; A Chandraker
Journal:  Am J Transplant       Date:  2012-08-17       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.